Ignacio Mena
Title
Cited by
Cited by
Year
Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro
R Feuer, I Mena, R Pagarigan, MK Slifka, JL Whitton
Journal of virology 76 (9), 4430-4440, 2002
2122002
A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses
S Tripathi, VRMT Balasubramaniam, JA Brown, I Mena, A Grant, ...
PLoS pathogens 13 (3), e1006258, 2017
1882017
Origins of the 2009 H1N1 influenza pandemic in swine in Mexico
I Mena, MI Nelson, F Quezada-Monroy, J Dutta, R Cortes-Fernández, ...
Elife 5, e16777, 2016
1832016
Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance
JR Gebhard, CM Perry, S Harkins, T Lane, I Mena, VC Asensio, ...
The American journal of pathology 153 (2), 417-428, 1998
1781998
Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease
R Feuer, I Mena, RR Pagarigan, S Harkins, DE Hassett, JL Whitton
The American journal of pathology 163 (4), 1379-1393, 2003
1722003
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
L Miorin, T Kehrer, MT Sanchez-Aparicio, K Zhang, P Cohen, RS Patel, ...
Proceedings of the National Academy of Sciences 117 (45), 28344-28354, 2020
1612020
The role of B lymphocytes in coxsackievirus B3 infection
I Mena, CM Perry, S Harkins, F Rodriguez, J Gebhard, JL Whitton
The American journal of pathology 155 (4), 1205-1215, 1999
1561999
Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology
I Mena, C Fischer, JR Gebhard, CM Perry, S Harkins, JL Whitton
Virology 271 (2), 276-288, 2000
1402000
Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids
I Mena, A Vivo, E Pérez, A Portela
Journal of Virology 70 (8), 5016-5024, 1996
1301996
Using Recombinant Coxsackievirus B3 To Evaluate the Induction and Protective Efficacy of CD8+ T Cells during Picornavirus Infection
MK Slifka, R Pagarigan, I Mena, R Feuer, JL Whitton
Journal of virology 75 (5), 2377-2387, 2001
1052001
Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication
I Mena, E Jambrina, C Albo, B Perales, J Ortín, M Arrese, D Vallejo, ...
Journal of virology 73 (2), 1186-1194, 1999
1001999
An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus
M Juozapaitis, ÉA Moreira, I Mena, S Giese, D Riegger, A Pohlmann, ...
Nature communications 5 (1), 1-8, 2014
872014
Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins.
I Mena, M Castillo, A Vivo, A Portela
Journal of general virology 80 (7), 1635-1645, 1999
871999
Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system
I Mena, S De La Luna, C Albo, J Martín, A Nieto, J Ortín, A Portela
Journal of General Virology 75 (8), 2109-2114, 1994
851994
Pandemic H1N1 influenza isolated from free-ranging Northern Elephant Seals in 2010 off the central California coast
T Goldstein, I Mena, SJ Anthony, R Medina, PW Robinson, DJ Greig, ...
PLoS One 8 (5), e62259, 2013
662013
Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication
SK Kuss-Duerkop, J Wang, I Mena, K White, G Metreveli, R Sakthivel, ...
PLoS pathogens 13 (9), e1006635, 2017
532017
Newcastle disease virus-vectored H7 and H5 live vaccines protect chickens from challenge with H7N9 or H5N1 avian influenza viruses
Q Liu, I Mena, J Ma, B Bawa, F Krammer, YS Lyoo, Y Lang, I Morozov, ...
Journal of virology 89 (14), 7401-7408, 2015
522015
Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency
R Feuer, I Mena, RR Pagarigan, DE Hassett, JL Whitton
Medical microbiology and immunology 193 (2), 83-90, 2004
422004
Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant
E Crisci, H Almanza, I Mena, L Cordoba, E Gómez-Casado, JR Caston, ...
Virology 387 (2), 303-312, 2009
402009
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
R Rathnasinghe, S Jangra, A Cupic, C Martínez-Romero, LCF Mulder, ...
MedRxiv, 2021
382021
The system can't perform the operation now. Try again later.
Articles 1–20